Postoperative Fevers in Pediatric Solid Tumor Patients How Should They be Managed?

被引:3
|
作者
Hendershot, Eleanor [1 ]
Chang, Ann [2 ]
Colapinto, Kimberly [3 ]
Gerstle, J. Ted [3 ]
Malkin, David [1 ]
Sung, Lillian [1 ]
机构
[1] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Hematol Oncol BMT Immunol, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Div Gen Surg, Toronto, ON M5G 1X8, Canada
关键词
postoperative; fever; solid tumor; treatment; pediatrics; INVASIVE MYCOSES; CHILDREN; CANCER;
D O I
10.1097/MPH.0b013e3181a6dd21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is unclear how aggressively postoperative fevers should be managed in immunosuppressed pediatric oncology patients after major surgery. Little data exists on this subject. Therefore, it retrospective study of patients treated at our center was undertaken to examine this. Purposes: (I) to describe the prevalence of fever and infection in postoperative pediatric solid tumor patients undergoing primary tumor resection, (2) to examine the risk factors that contribute to the development of postoperative infections, and (3) to describe the variation in practice in managing fevers. Methods: Chart reviews were performed on patients diagnosed with a spectrum of tumor types from January 2000 to October 2005 who received preoperative chemotherapy, followed by tumor resection. Results: Ninety-eight children met inclusion criteria and 73 (74%) developed fevers postoperatively; 14% of these had documented infections and 1 patient died from sepsis. Factors associated with increased risk of infection were a diagnosis of neuroblastoma (P = 0.015), and surgery longer than 8 hours (P = 0.059). The investigation and management of postoperative fevers varied in these patients. Conclusions: Postoperative fevers may be indicative of severe infection. We suggest that a standardized approach to the management of these patients, including prompt physical assessment, clinical investigations, and empiric antibiotic consideration is vital to minimize complications.
引用
收藏
页码:485 / 488
页数:4
相关论文
共 50 条
  • [21] How should biliary lithiasis be managed?
    Gambiez, L
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (01): : S128 - S139
  • [22] How should blindness in children be managed?
    Bowman, RJC
    EYE, 2005, 19 (10) : 1037 - 1043
  • [23] HOW SHOULD ANOTHER CAMELFORD BE MANAGED
    MAYONWHITE, RT
    BRITISH MEDICAL JOURNAL, 1993, 307 (6901): : 398 - 399
  • [24] How mammillary fistulas should be managed
    Hanavadi, S
    Pereira, G
    Mansel, RE
    BREAST JOURNAL, 2005, 11 (04): : 254 - 256
  • [25] How Should Symptomatic Central Vein Stenosis be Managed in Hemodialysis Patients?
    Agarwal, Anil K.
    Haddad, Nabil J.
    Khabiri, Hooman
    SEMINARS IN DIALYSIS, 2014, 27 (03) : 278 - 281
  • [26] How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy, SSK
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2000, 67 (06) : 401 - 402
  • [27] How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?
    Danovitch, GM
    KIDNEY INTERNATIONAL, 2002, 61 : S68 - S72
  • [28] Patients with refractory reflux symptoms: What do they have and how should they be managed?
    Kahrilas, P. J.
    Keefer, L.
    Pandolfino, J. E.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (09): : 1195 - 1201
  • [29] How should classic Whipple disease be managed?
    Florence Fenollar
    Didier Raoult
    Nature Reviews Gastroenterology & Hepatology, 2010, 7 : 246 - 248
  • [30] How should hepatitis C be managed in patients aged 65 years and older?
    Sam Nourani
    Paul J Pockros
    Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 : 22 - 23